Logo image
A comprehensive guide on the optimal timing of PCI in the setting of acute coronary syndrome: An updated meta-analysis
Journal article   Peer reviewed

A comprehensive guide on the optimal timing of PCI in the setting of acute coronary syndrome: An updated meta-analysis

Ahmed Abdelaziz, Hanaa Elsayed, Karim Atta, Ahmed Mechi, Hallas Kadhim, Aya Moustafa Aboutaleb, Ahmed Elaraby, Mohamed Hatem Ellabban, Mahmoud Eid, Hadeer Elsaeed AboElfarh, …
International journal of cardiology, Vol.400, p.131774
04/01/2024
PMID: 38211674

Abstract

Delayed intervention Early intervention NSTE-ACS PCI STEMI
Invasive revascularization is recommended for cohorts of patients with ST-elevation myocardial infarction (STEMI) and non-ST-elevation acute coronary syndrome (NSTE-ACS). However, the optimal timing of invasive revascularization is still controversial and no defined consensus is established. We aim to give a comprehensive appraisal on the optimal timing of invasive strategy in the heterogenous population of ACS. Relevant studies were assessed through PubMed, Scopus, Web of science, and Cochrane Library from inception until April 2023. Major adverse cardiovascular events (MACE) and all-cause mortality were our primary outcomes of interest, other secondary outcomes were cardiac death, TVR, MI, repeat revascularization, recurrent ischemia, and major bleeding. The data was pooled as odds ratio (OR) with its 95% confidence interval (CI) in a random effect model using STATA 17 MP. A total of 26 studies comprising 21,443 patients were included in the analysis. Early intervention was favor to decrease all-cause mortality (OR = 0.79, 95% CI: 0.64 to 0.98, p = 0.03), when compared to delayed intervention. Subgroup analysis showed that early intervention was significantly associated with all-cause mortality reduction in only NSTE-ACS (OR = 0.83, 95% CI [0.7 to 0.99], p = 0.04). However, there was no significant difference between early and delayed intervention in terms of MACE, cardiac death, TVR, MI, repeat revascularization, recurrent ischemia, and major bleeding. An early intervention was associated with lower mortality rates compared to delayed intervention in NSTE-ACS with no significant difference in other clinical outcomes. PROSPERO registration: CRD42023415574. •What this study adds: The optimal timing of PCI intervention is still controversial, with conflicting data in the literature. Some recommendations of the early approach were addressed without analytic evidence. Our systematic review and meta-analysis of 26 included studies showed that. Early invasive intervention was associated with lower odds of all-cause mortality, and subgroup analysis based on disease type showed lower mortality was noted in NSTE-ACS cohorts. We used TSA for power analysis, ensuring adequately that the evidence of mortality reduction is strong.•How this study might affect research, practice or policy: This study can be a guide of recommending early an invasive approach to ACS cohorts, especially NSTE-ACS. This new finding should be validated with large-volume RCTs with long-term outcomes.

Metrics

1 Record Views

Details

Logo image